false
OasisLMS
Catalog
Adrenal, Pituitary, Gonad, and Neuroendocrine Stra ...
Disease State Network Year-in-Review-PGAN
Disease State Network Year-in-Review-PGAN
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In this video summary, several studies in the field of pituitary, gonadal, adrenal, and neuroendocrine tumors are discussed. The first study focuses on the use of plasma steroid profiling to distinguish different types of adrenal tumors. Researchers found that combining plasma steroid profiling with metanephrines and adrenal lesion size can help identify the type of adrenal tumor with high accuracy. The second study examines the use of ACTH stimulation during adrenal venous sampling and its impact on lateralization. The study found that ACTH stimulation can underestimate surgically curable primary aldosterone. The third study investigates the relationship between acromegaly and the risk of developing non-pituitary tumors. The study found that acromegaly patients have an increased risk of certain cancers, including colorectal, anal, kidney, and ureter malignancies. The fourth study looks at the effectiveness of oral octreotide in the treatment of acromegaly. The study found that oral octreotide was non-inferior to injectable somatostatin receptor ligands in controlling IGF-1 levels. The fifth study focuses on the use of ocilodrostat in the treatment of Cushing's disease. The study found that ocilodrostat effectively normalized urinary free cortisol levels in patients with Cushing's disease. Overall, these studies provide valuable insights into the diagnosis and treatment of pituitary, gonadal, adrenal, and neuroendocrine tumors.
Keywords
pituitary tumors
gonadal tumors
adrenal tumors
neuroendocrine tumors
plasma steroid profiling
ACTH stimulation
acromegaly
oral octreotide
Cushing's disease
×
Please select your language
1
English